Drugs / AdC6-HIVgp140
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05182125 | Nov 2021 → Aug 2023 | HIV infectious disease | HIV Vaccine Trials Network | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdC6-HIVgp140 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05182125 ↗ |
| Modality | Vaccine | “HIV-1 vaccines based on chimpanzee serotypes of adenovirus expressing clade C gp140” NCT05182125 ↗ |
| Route | Intramuscular | “to be administered as two separate 1 mL IM injections into the deltoid of the non-dominant arm unless medically contraindicated at month 0.” NCT05182125 ↗ |